AGILENT TECHNOLOGIES INC (A:NYSE)
$140.73 2.84 (2.0596%)
Analysed AGILENT TECHNOLOGIES INC (A:NYSE) News Sources
In Vitro Toxicology Testing Market to Exceed $20.97 Billion by 2031 as Non-Animal Testing & AI Adoption Accelerate - Analysis by Product, Toxicity Endpoints & Type, Technology, Method, Service, Region
23-07-2026
yahoo.com
Reading Between The Lines Of DHR's Latest Call
24-07-2026
trefis.com
1 Healthcare Stock to Research Further and 2 We Avoid
24-07-2026
yahoo.com
Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?
24-07-2026
yahoo.com
Can GE HealthCare Sustain Growth in Q2 Amid Persistent Cost Headwinds?
24-07-2026
yahoo.com
What to Expect From Agilent Technologies' Q3 2026 Earnings Report
24-07-2026
barchart.com
Why Agilent Technologies (A) Is Up 5.4% After New FDA Nod For OPDIVO Cancer Test
25-07-2026
yahoo.com
Is Agilent Technologies (A) Undervalued Following Its FDA Approval For OPDIVO Companion Diagnostics?
25-07-2026
yahoo.com
DXCM Q2 Results Likely to Reflect Strong G7 & Reimbursement Expansion
27-07-2026
yahoo.com
Stryker's Q2 Results Likely to Reflect Recovery of Q1 Deferred Orders
27-07-2026
yahoo.com
What is the current price of AGILENT TECHNOLOGIES INC (A:NYSE)?
The current price of AGILENT TECHNOLOGIES INC (A:NYSE) is $140.73.
AGILENT TECHNOLOGIES INC (A:NYSE) absolute price change since previous trading day?
The absolute price change of AGILENT TECHNOLOGIES INC (A:NYSE) since the previous trading day is $2.84.
AGILENT TECHNOLOGIES INC (A:NYSE) percentage price change since previous trading day?
The percentage price change of AGILENT TECHNOLOGIES INC (A:NYSE) since the previous trading day is 2.0596%.
What is the most recent average sentiment score for AGILENT TECHNOLOGIES INC (A:NYSE)?
The most recent average sentiment score for AGILENT TECHNOLOGIES INC (A:NYSE) is 73 out of 100.
What is the most recent average sentiment for AGILENT TECHNOLOGIES INC (A:NYSE)?
The most recent sentiment for AGILENT TECHNOLOGIES INC (A:NYSE) is .
SEC-8K** Filing Available For AGILENT TECHNOLOGIES INC (A:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.